Metabolic syndrome
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Among 11,673 Japanese subjects who had undergone an annual health check-up between April 2019 and March 2020 at the Health Planning Center of Nihon University Hospital, 10,373 subjects (females, 4,056; males, 6,317) were recruited for this study.
Exclusion criteria
Exclusion criteria: The exclusion criteria included refusal to provide consent for participation in the study, current lipid-modified, treatment, and diagnosis of cerebral and/or cardiovascular disease, serum triglyceride levels more than 400mg/dL, and no measurement of abdominal circumference and serum lipid level.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary efficacy parameter was the relationship between the TG/HDL-C ratio and abdominal obesity by gender. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoint was the relationship between the TG/HDL-C ratio and the prevalence of Mets and its components as cardio-metabolic risk by gender. | — |
Countries
Japan
Contacts
Nihon University Hospital Health Planning Center